Clinical Trial Update: An Optional Investigation of Biomarkers of Efficacy

View source ↗

Summary

Circassia Limited reports an optional biomarker study for efficacy in rhinoconjunctivitis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis

Snippet

Sponsor: Circassia Limited | Conditions: Rhinoconjunctivitis | Status: COMPLETED